跳至主要内容
临床试验/DRKS00032096
DRKS00032096招募中Unknown

Gluten degrading-probiotic in the dietary management of symptomatic Celiac disease patients: a randomized, multicentric, placebo-controlled, double-blinded study - ProCeliac

Evonik Operations GmbH0 个研究点目标入组 100 人开始时间: 2023年6月26日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • BMI 17.5 – 35 kg/m2
  • - Non-smoker
  • - Past celiac disease diagnosis confirmed by medical report
  • - Gluten free diet (GFD) for at least two years
  • - Celiac disease patients with persistent IBS-type symptoms with no clinical evidence of other medical conditions to explain the symptoms
  • - IBS-SSS score of at least mild symptoms (IBS-SSS score = 75) during screening assessment
  • - Apart from celiac disease diagnosis, subject is in good physical and mental health as established by medical history, physical examination, vital signs, results of biochemistry, haematology
  • - Written consent to participate in the study
  • - Able and willing to follow the study procedures
  • - Visit 1: Confirmed at least mild symptoms during run-in phase (on average IBS-SSS score > 50)

排除标准

  • (1) Relevant history or presence of any severe medical disorder, potentially interfering with this study (e.g. heavy depression, diabetes, acute cancers within last 3 years except basal cell carcinoma of the skin, etc.)
  • (2) Subject under prescription for medication or taking dietary supplements possibly interfering with this study (such as corticosteroids, anti-inflammatory drugs, anti-spasmodic, laxatives and anti-diarrheic drugs or other digestive auxiliaries, fibers, probiotics etc.) within 4 weeks prior to study start or during the study. Stable doses of vitamin and mineral dietary supplements for at least 3 months is allowed.
  • (3) Intake of antibiotics in the last 3 months
  • (4) Use of PPIs in the last month prior to screening
  • (5) Significant changes in lifestyle or medication (within last 2 months) or surgical intervention
  • (6) Subjects consuming
  • food or drinks claimed as ‘probiotic’ more than once weekly
  • protein shakes more than once weekly
  • (7) Subjects with stool frequency of = 2 stools per week
  • (8) Subjects with history of drug, alcohol or other substance abuse within the last 5 years
  • (9) Relevant allergy or known hypersensitivity against compounds of the study preparations
  • (10) Participation in another clinical study within the last 4 weeks and concurrent participation in another clinical study
  • (11) Anticipating any planned major changes in lifestyle, dietary habits or physical activity levels for the duration of the study
  • (12) Known pregnancy, breastfeeding or intention to become pregnant during the study. A pregnancy test will be conducted during screening and all visits at the study site
  • (13) Subjects considered inappropriate for the study by investigators, including subjects who are unable or unwilling to show compliance with the protocol

研究者

相似试验

Gluten degrading-probiotic in the dietary management... | 临床试验